High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma
Supaporn Yangngam, Suyanee Thongchot, Ananya Pongpaibul, Kulthida Vaeteewoottacharn, Somchai Pinlaor, Peti Thuwajit, Seiji Okada, Chanitra Thuwajit · Journal of Cancer · 2020
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2020
Abstract
Interleukin 33 (IL-33) promotes cholangiocarcinoma (CCA) genesis in a mouse model, however, its function in human CCA has not been clearly understood.This study was aimed to investigate IL-33 level in CCA tissues and its clinicopathological correlations.The results revealed that IL-33 was found in both cancer cells and stromal cancer-associated fibroblast (CAFs) staining patterns which were divided into high (CH) and low level (CL) in cancer cells; and presence (FP) and absence (FA) in CAFs.Kaplan-Meier analysis showed that patients in the CL group were significantly correlated with a short 2-year survival time (P = 0.027).The CL/FP group had a shorter survival time compared to the other groups with statistical significance for 2-year (P = 0.030) and 5-year (P = 0.023) survivals.In contrast, CH/FP patients had significantly greater 2-year (P = 0.003) and 5-year (P = 0.003) survivals.Univariate and multivariate analysis confirmed that CL/FP was a significantly independent risk factor whereas CH/FP was a significant protective factor in CCA patients.High IL-33 expressing CCA cells had low migration, but they showed increased migration when IL-33 expression was knocked down.The low level of recombinant human IL-33 (rhIL-33) (0.002 -2 ng/ml) could promote CCA cell migration, in contrast to the suppressive effect at a high dose (20 -200 ng/ml).In conclusion, the combination of high IL-33 level in cancer cells and CAFs is a potentially good prognosis marker in CCA patients.The in vitro migration suppressive effect of IL-33 may be the potential mechanism supporting its role as a good prognostic marker in CCA patients.The obtained results strengthen IL-33 as a promising predictor and therapeutic target for CCA.
Open the resolved locator · 10.7150/jca.48327
Metadata licence: OpenAlex metadata (CC0)